Subcellular localization of iron regulatory proteins to Golgi and ER membranes.
Interaction between iron regulatory proteins and iron responsive elements on certain mRNAs is at the core of regulation of intracellular iron homeostasis. Previous results suggested that in cultured cells iron regulatory proteins (IRPs) exist in cytosolic and microsomal subcellular locations and that this distribution is affected by cellular iron status. In this study, we tested the hypothesis that the membrane-associated fractions of iron regulatory proteins are specifically in the endoplasmic reticulum and Golgi membranes. Confocal microscopy revealed that IRP1 could be co-localized to the endoplasmic reticulum and the Golgi apparatus. To examine the intracellular distribution of IRPs biochemically, we used rats fed normal or iron-deficient diets. As expected, the IRPs were found predominantly in the cytosolic fraction. However, subfractionation of crude microsomal preparations revealed IRP1 in the Golgi apparatus. In animals fed an iron-deficient diet, IRP1 was found in the Golgi apparatus and the endoplasmic reticulum. To identify the mechanisms and factors involved in the localization of iron regulatory proteins in the cytosol and membrane fractions, cells were treated with a phorbol ester, a protein kinase C inhibitor (chelerythrine), hydrogen peroxide, interleukin-1beta, and 1,2-bis-(o-aminophenoxy)-ethane-N,N,-N'N'-tetraacetic acid tetraacetoxy-methyl ester. The results indicate that iron-regulatory-protein-binding activity in the membrane fraction can be altered by cell stress or iron status and that phosphorylation plays a role in the translocation. As a result of this study we propose a novel model for intracellular distribution of IRPs and identify differences between the two iron regulatory proteins.
Patton
Stephanie M
SM
Department of Neurosurgery, G.M. Leader Family Laboratory for Alzheimer's Disease Research, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA.
Piñero
Domingo J
DJ
Surguladze
Nodar
N
Beard
John
J
Connor
James R
JR
D000470:Alkaloids; D000818:Animals; D053119:Benzophenanthridines; D015415:Biomarkers / Q000378:metabolism; D002460:Cell Line; D002614:Chelating Agents / Q000378:metabolism; D004721:Endoplasmic Reticulum / Q000378:metabolism*; D004791:Enzyme Inhibitors / Q000378:metabolism; D006056:Golgi Apparatus / Q000378:metabolism*; D006706:Homeostasis; D006801:Humans; D007425:Intracellular Membranes / Q000378:metabolism*; D007501:Iron / Q000378:metabolism; D035941:Iron Regulatory Protein 1 / Q000235:genetics / Q000378:metabolism*; D035942:Iron Regulatory Protein 2 / Q000235:genetics / Q000378:metabolism*; D019266:Iron, Dietary; D035925:Iron-Regulatory Proteins / Q000378:metabolism*; D008099:Liver / Q000166:cytology / Q000378:metabolism; D010617:Phenanthridines / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D013347:Subcellular Fractions / Q000737:chemistry; D013755:Tetradecanoylphorbol Acetate / Q000378:metabolism
D000470:Alkaloids; D053119:Benzophenanthridines; D015415:Biomarkers; D002614:Chelating Agents; D004791:Enzyme Inhibitors; D019266:Iron, Dietary; D035925:Iron-Regulatory Proteins; D010617:Phenanthridines; D012333:RNA, Messenger; D007501:Iron; C016299:chelerythrine; D035941:Iron Regulatory Protein 1; D035942:Iron Regulatory Protein 2; D013755:Tetradecanoylphorbol Acetate